This is the second and final phase of the overall capacity addition of ?195 kL which was under construction at Unit IV Bidar facility
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company reported sustained increase in formulations' share despite slowdown in productivity of Gagillapur facility
The company expects meaningful revenue contribution from this long-term agreement
The CDMO upgrade represents a transformational step for Remedium Lifecare
Tatva Chintan Pharma Chem receives export order worth $35, 55,000
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The company is committed to revolutionizing API development by advancing synthesis and analytical processes that enhance quality and impact lives
Subscribe To Our Newsletter & Stay Updated
